Overall, Metformin, beyond its classical action as an antidiabetic drug, reveals significant therapeutic potential against COVID-19, including its influence as an antimicrobial agent, immunomodulatory agent, and ACE2 stabilizer, and agent that regulates gut microbiota composition and maintains gut homeostasis. This evidence concerns the gene ACE2 and COVID-19.